共 34 条
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI
被引:28
作者:
de Rooij, Maarten
[1
]
Allen, Clare
[2
]
Twilt, Jasper J.
[1
]
Thijssen, Linda C. P.
[1
]
Asbach, Patrick
[3
,4
,5
,6
]
Barrett, Tristan
[7
]
Brembilla, Giorgio
[8
]
Emberton, Mark
[9
,10
]
Gupta, Rajan T.
[11
]
Haider, Masoom A.
[12
]
Kasivisvanathan, Veeru
[9
,10
]
Logager, Vibeke
[13
]
Moore, Caroline M.
[9
,10
]
Padhani, Anwar R.
[11
]
Panebianco, Valeria
[12
]
Puech, Philippe
[13
]
Purysko, Andrei S.
[14
,15
,16
]
Renard-Penna, Raphaele
[17
]
Richenberg, Jonathan
[18
]
Salomon, Georg
[19
]
Sanguedolce, Francesco
[20
,21
]
Schoots, Ivo G.
[22
]
Thony, Harriet C.
[22
]
Turkbey, Baris
[23
]
Villeirs, Geert
[24
]
Walz, Jochen
[25
]
Barentsz, Jelle
[26
]
Giganti, Francesco
[2
,9
]
机构:
[1] Radboud Univ Nijmegen Med Ctr, Dept Med Imaging, Nijmegen, Netherlands
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England
[3] Charite Univ Med Berlin, Dept Radiol, Berlin, Germany
[4] Free Univ Berlin, Berlin, Germany
[5] Humboldt Univ, Berlin, Germany
[6] Berlin Inst Hlth, Berlin, Germany
[7] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge, England
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy
[9] UCL, Div Surg & Intervent Sci, London, England
[10] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England
[11] Duke Univ Med Ctr, Dept Radiol, Durham, NC USA
[12] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Joint Dept Med Imaging, Sinai Hlth Syst, Toronto, ON, Canada
[13] Herlev Gentofte Univ Hosp, Dept Radiol, Herlev, Denmark
[14] Cleveland Clin, Diagnost Inst, Abdominal Imaging Sect, Cleveland, OH USA
[15] Cleveland Clin, Diagnost Inst, Nucl Radiol Dept, Cleveland, OH USA
[16] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA
[17] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Radiol, Paris, France
[18] Brighton & Sussex Univ Hosp NHS Trust, Dept Imaging, Brighton, E Sussex, England
[19] Univ Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany
[20] Univ Sassari, Dept Med Surg & Pharm, Sassari, Italy
[21] Fundacio Puigvert, Dept Urol, Barcelona, Spain
[22] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[23] NCI, NIH, Mol Imaging Branch, Bethesda, MD USA
[24] Ghent Univ Hosp, Dept Med Imaging, Ghent, Belgium
[25] Inst Paoli Calmettes Canc Ctr, Dept Urol, Marseille, France
[26] Andros Clin, Arnhem, Netherlands
关键词:
Magnetic resonance imaging;
Prostatic neoplasms;
Quality control;
CANCER;
ACCURACY;
D O I:
10.1007/s00330-024-10795-4
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI.We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.AbstractMultiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images.Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.The prostate imaging quality (PI-QUAL) scoring system was the first standardised quantification method that demonstrated the potential for clinical benefit by relating image quality to cancer detection ability by MRI. We present the updated version of PI-QUAL (PI-QUAL v2) which applies to prostate MRI performed with or without intravenous contrast medium using a simplified 3-point scale focused on critical technical and qualitative image parameters.Clinical relevance statementHigh image quality is crucial for prostate MRI, and the updated version of the PI-QUAL score (PI-QUAL v2) aims to address the limitations of version 1. It is now applicable to both multiparametric MRI and MRI without intravenous contrast medium.Key PointsHigh-quality images are essential for prostate cancer diagnosis and management using MRI.PI-QUAL v2 simplifies image assessment and expands its applicability to prostate MRI without contrast medium.PI-QUAL v2 focuses on critical technical and qualitative image parameters and emphasises T2-WI and DWI.
引用
收藏
页码:7068 / 7079
页数:12
相关论文